The portable vascular doppler market has seen considerable growth due to a variety of factors.
• The portable vascular doppler market has grown robustly in recent years. It is set to increase from $1.66 billion in 2024 to $1.76 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%.
The growth is driven by the rising prevalence of vascular diseases, technological advancements, an aging population, higher healthcare spending, awareness campaigns, improvements in point-of-care testing, and the expansion of telemedicine.
The portable vascular doppler market is expected to maintain its strong growth trajectory in upcoming years.
• The portable vascular Doppler market is projected to grow to $2.21 billion by 2029 at a CAGR of 5.9%.
The expansion is attributed to the increasing demand for miniaturization, personalized medicine, remote patient monitoring, cost efficiency, regulatory support, and market growth in emerging economies. Key trends include AI-powered diagnostics, wireless connectivity, advanced data analytics, improved user interfaces, IoT integration, and patient-focused design.
The escalating instances of cardiovascular diseases are anticipated to spur the expansion of the portable vascular doppler market in future. Cardiovascular diseases, known in short as CVD, are a range of disorders having an impact on the heart and its associated blood vessels. The increasing global propensity for unhealthy processed foods and a declining intake of fruits and vegetables can be associated with the surge in CVD. Additionally, factors such as inactive lifestyles, poor dietary selections, and rampant obesity greatly contribute to cardiovascular complications. Portable vascular doppler apparatuses boost the diagnostic abilities for healthcare professionals, which leads to punctual identification and treatment of cardiovascular conditions, thereby ameliorating patient results and minimizing the chance of issues attributed to vascular illnesses. For instance, in January 2024, as stated by the American Heart Association, a nonprofit entity based in the US, the tally of fatalities caused by cardiovascular diseases was 931,578, surface from 928,741 in 2023. In addition, the age-adjusted mortality rate due to cardiovascular illness also witnessed a slight increase, rising to 233.3 per 100,000, signifying a 4.0% surge from the figure of 224.4 per 100,000 noted the preceding year. Thus, the rising incidence of cardiovascular diseases is acting as a catalyst for the portable vascular doppler market growth.
The portable vascular doppler market covered in this report is segmented –
1) By Type: Type I, Type II
2) By Disease Type: Atherosclerosis, Peripheral Artery Disease (PAD), Carotid Artery Disease, Pulmonary Embolism, Collagen Vascular Disease, Cerebrovascular Disease, Other Disease Types
3) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Type I: Handheld Vascular Doppler, Single-Channel Vascular Doppler, Doppler With Audio And Visual Display
2) By Type II: Multi-Channel Vascular Doppler, Doppler With Advanced Imaging Features, Doppler With Enhanced Signal Processing, Vascular Doppler With Integrated Pulse Oximetry
Leading firms within the portable vascular doppler market are honing their focus on the creation of handheld, wireless vascular doppler technology with an aim to boost diagnostic precision and convenience, therefore, stimulating the growth of market share and customer trust. Such wireless handheld vascular Doppler instruments are user-friendly, mobile and employ Doppler ultrasound technology for assessing and overseeing blood circulation in the vascular system. They offer real-time data through their wireless connectivity feature. For instance, in June 2022, a US-based medical apparatus manufacturing company, Remington Medical Inc., unveiled a state-of-the-art wireless handheld vascular doppler device named VascuChek. This device comes equipped with a 9 MHz wave system that operates continuously and eliminates the necessity for a bulky transceiver box and tethered probes, resulting in greater control and mobility for the user. It holds the capacity for both intraoperative (microvascular and vascular) as well as transcutaneous blood flow analysis, thereby augmenting its usability in diverse medical applications. This groundbreaking device aims to transform the way doctors evaluate patients' blood flow during clinical and surgical processes.
Major companies operating in the portable vascular doppler market are:
• Siemens Healthineers
• GE HealthCare Technologies Inc.
• CooperSurgical Inc.
• Natus Medical Incorporated
• Schiller AG
• Edan Instruments Inc.
• Meditech Equipment Co. Ltd.
• A.D. Instruments Pty Ltd.
• CHISON Medical Technologies Co. Ltd
• Huntleigh Healthcare Ltd.
• Medistim ASA
• Compumedics Limited
• LRE Medical GmbH
• Perimed AB
• Nicolet Vascular Inc
• Parks Medical Electronics Inc.
• Koven Technology Inc.
• Sifin Diagnostics GmbH
• Hadeco Inc.
• D.E. Hokanson Inc.
• Advanced Instrumentations Inc.
• ELCAT GmbH
• Infrascan Inc.
• Multigon Industries Inc.
• Newman Medical LLC
• SonoSite Inc.
• Sunray Medical Apparatus Co. Ltd.
• Viasonix Ltd.
• Wallach Surgical Devices Inc
• Vcomin Technology Limited
North America was the largest region in the portable vascular doppler market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the portable vascular doppler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.